These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 23945500)

  • 21. The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity.
    Jackson JP; Brouwer KR
    Methods Mol Biol; 2019; 1981():75-85. PubMed ID: 31016648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approach.
    van Ertvelde J; Verhoeven A; Maerten A; Cooreman A; Santos Rodrigues BD; Sanz-Serrano J; Mihajlovic M; Tripodi I; Teunis M; Jover R; Luechtefeld T; Vanhaecke T; Jiang J; Vinken M
    J Biomed Inform; 2023 Sep; 145():104465. PubMed ID: 37541407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.
    Becker RA; Ankley GT; Edwards SW; Kennedy SW; Linkov I; Meek B; Sachana M; Segner H; Van Der Burg B; Villeneuve DL; Watanabe H; Barton-Maclaren TS
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):514-37. PubMed ID: 25863193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitors.
    Welch MA; Köck K; Urban TJ; Brouwer KL; Swaan PW
    Drug Metab Dispos; 2015 May; 43(5):725-34. PubMed ID: 25735837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary study on Emodin alleviating alpha-naphthylisothiocyanate-induced intrahepatic cholestasis by regulation of liver farnesoid X receptor pathway.
    Ding Y; Xiong XL; Zhou LS; Yan SQ; Qin H; Li HR; Zhang LL; Chen P; Yao C; Jiang ZX; Zhao L
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):805-811. PubMed ID: 27707957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-speed screening and QSAR analysis of human ATP-binding cassette transporter ABCB11 (bile salt export pump) to predict drug-induced intrahepatic cholestasis.
    Hirano H; Kurata A; Onishi Y; Sakurai A; Saito H; Nakagawa H; Nagakura M; Tarui S; Kanamori Y; Kitajima M; Ishikawa T
    Mol Pharm; 2006; 3(3):252-65. PubMed ID: 16749857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Adverse Outcome Pathway Linking Organohalogen Exposure to Mitochondrial Disease.
    McMinn B; Duval AL; Sayes CM
    J Toxicol; 2019; 2019():9246495. PubMed ID: 31057609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat precision-cut liver slices predict drug-induced cholestatic injury.
    Starokozhko V; Greupink R; van de Broek P; Soliman N; Ghimire S; de Graaf IAM; Groothuis GMM
    Arch Toxicol; 2017 Oct; 91(10):3403-3413. PubMed ID: 28391356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in silico identification of human bile salt export pump (ABCB11) inhibitors associated with cholestatic drug-induced liver injury.
    Xi L; Yao J; Wei Y; Wu X; Yao X; Liu H; Li S
    Mol Biosyst; 2017 Jan; 13(2):417-424. PubMed ID: 28092392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice.
    Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Yao J; Liu K
    Pharm Res; 2015 Nov; 32(11):3688-98. PubMed ID: 26040663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
    Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF
    Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The bile salt export pump (BSEP) in health and disease.
    Kubitz R; Dröge C; Stindt J; Weissenberger K; Häussinger D
    Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):536-53. PubMed ID: 22795478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Warner DJ; Chen H; Cantin LD; Kenna JG; Stahl S; Walker CL; Noeske T
    Drug Metab Dispos; 2012 Dec; 40(12):2332-41. PubMed ID: 22961681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations?
    El Sherrif Y; Potts JR; Howard MR; Barnardo A; Cairns S; Knisely AS; Verma S
    Liver Int; 2013 Sep; 33(8):1266-70. PubMed ID: 23750872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.
    Pauli-Magnus C; Meier PJ; Stieger B
    Semin Liver Dis; 2010 May; 30(2):147-59. PubMed ID: 20422497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple compound-related adverse properties contribute to liver injury caused by endothelin receptor antagonists.
    Kenna JG; Stahl SH; Eakins JA; Foster AJ; Andersson LC; Bergare J; Billger M; Elebring M; Elmore CS; Thompson RA
    J Pharmacol Exp Ther; 2015 Feb; 352(2):281-90. PubMed ID: 25467130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools.
    de Lima Toccafondo Vieira M; Tagliati CA
    Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):581-97. PubMed ID: 24588537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.